Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low-and Middle-Income Countries

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 1, 2016, Pages 93-99

  Lall, Dorothy ^a   Cason, E ^b   Pasquel, F J ^c   Ali, M K ^a   Narayan, K M V ^b  

^a ETCM Hospital ^*  (India)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic Obstructive Pulmonary Disease (COPD); effectiveness; influenza vaccine; low and middle income countries

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; HEALTH CARE DELIVERY; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LOWEST INCOME GROUP; LUNG FUNCTION TEST; MIDDLE INCOME GROUP; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL STATUS; COMPLICATION; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DISEASE MANAGEMENT; ECONOMICS; INFLUENZA, HUMAN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; DISEASE MANAGEMENT; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84955393989     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1043518     Document Type: Article

References (35)

1. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223.
2. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003; 41: 46s-53s.
3. Rothbarth PH, Kempen BM, Sprenger MJ. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 1682-1685; discussion 5-6.
4. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 2355-2365.
5. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 36-44.
6. Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines 2013; 12: 1085-1094.
7. Noh JY, Kim WJ. Influenza vaccines: unmet needs and recent developments. Infect Chemother 2013; 45: 375-386.
8. Reperant LA, Rimmelzwaan GF, Osterhaus AD. Advances in influenza vaccination. F1000prime reports 2014; 6: 47.
9. Ambrose CS, Wu X, Jones T, Mallory RM. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 2012; 30: 6794-6801.
10. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006: Cd002733.
11. Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, Maranetra KN. The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine 2010; 28: 4045-4051.
12. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125: 2011-2020.
13. Kositanont U, Kanyok R, Wasi C, Wongsurakiat P, Suthamsmai T, Maranetra N. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study. J Med Assoc Thai 2004; 87: 964-969.
14. Menon B, Gurnani M, Aggarwal B. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination. Int J Clin Pract 2008; 62: 593-598.
15. Anar C, Bicmen C, Yapicioglu S, Unsal I, Halilcolar H, Yilmaz U. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease. New Microbiol 2010; 33: 117-127.
16. Wang CS, Wang ST, Lai CT, Lin LJ, Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007; 25: 1196-1203.
17. Breteler JK, Tam JS, Jit M, Ket JC, De Boer MR. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis. Vaccine 2013; 31: 5168-5177.
18. Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. J Med Assoc Thai 2003; 86: 497-508.
19. Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Hum Vaccin Immunother 2013; 9: 1500-1511.
20. Plans-Rubio P. Prevention and control of influenza in persons with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007; 2: 41-53.
21. Seo YB, Choi WS, Baek JH, et al. Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012. Hum Vaccin Immunother 2014; 10: 423-427.
22. Montserrat-Capdevila J, Godoy P, Marsal JR, Cruz I, Solanes M. [Effectiveness of influenza vaccination in preventing hospital admission due to exacerbations of chronic obstructive pulmonary disease]. Enferm Infecc Microbiol Clin 2014; 32: 70-5.
23. Kiyohara K, Kojimahara N, Sato Y, Yamaguchi N. Changes in COPD mortality rate after amendments to the Preventive Vaccination Law in Japan. Eur J Public Health 2013; 23: 133-139.
24. Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009; 64: 567-572.
25. Ayabe E, Kaneko N, Ohkuni Y, et al. [The efficacy of influenza vaccine for acute exacerbation of chronic obstructive lung disease in elderly patients]. Nihon Kokyuki Gakkai Zasshi 2008; 46: 511-515.
26. Sumitani M, Tochino Y, Kamimori T, Fujiwara H, Fujikawa T. Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients. Intern Med 2008; 47: 1189-1197.
27. Furumoto A, Ohkusa Y, Chen M, et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 2008; 26: 4284-4289.
28. Karwat KJ, Szpotanska M, Szulc Z, Chazan R. [The influence of influenza vaccination on asthma and chronic obstructive pulmonary disease]. Pneumonol Alergol Pol 2006; 74: 80-83.
29. Gorse GJ, O'Connor TZ, Young SL, et al. Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 2003; 21: 2133-2144.
30. Gorse GJ, Otto EE, Daughaday CC, et al. Influenza virus vaccination of patients with chronic lung disease. Chest 1997; 112: 1221-1233.
31. MRC Advisory Group on Pulmonary Function Tests. Trials of live attenuated influenza virus vaccine in patients with chronic obstructive airways disease. (MRC Advisory Group on Pulmonary Function Tests in relation to live influenza vaccines). Br J Dis Chest 1984; 78: 236-247.
32. Bartsch P, Dierckx JP, Frans A, Gillard C, Jovanovic D, Stanescu D. Live influenza vaccine in patients with chronic bronchopulmonary diseases. A multicenter study with two consecutive vaccinal strains. Dev Biol Stand 1977; 39: 113-121.
33. Prevost JM, Vereerstraeten-Schmerber J, Lamy F, De Koster JP. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Clinical and immunological evaluation. Scand J Respir Dis 1975; 56: 58-69.
34. Fell PJ, Watson NP, O'Donnell HF, Simmons RL, Hasell SK. Longer term effects of live influenza vaccine in patients with chronic pulmonary disease. Lancet 1977; 1: 1282-1284.
35. Howells CH, Tyler LE. Prophylactic use of influenza vaccine in patients with chronic bronchitis. A pilot trial. Lancet 1961; 2: 1428-1432.